EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
92 hedge funds and large institutions have $582M invested in Eidos Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 16 closing their positions.
Holders
92
Holders Change
+3
Holders Change %
+3.37%
% of All Funds
1.89%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
19
Increased
29
Reduced
24
Closed
16
Calls
$1.66M
Puts
$5K
Net Calls
+$1.65M
Net Calls Change
+$588K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$33.1M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$11.3M |
3 |
3
Citigroup
New York
|
$5.21M |
4 |
IC
4
Ikarian Capital
Dallas,
Texas
|
$4.77M |
5 |
![]()
5
Artisan Partners
Milwaukee,
Wisconsin
|
$19M |